{
    "organizations": [],
    "uuid": "9f8c82931c58a60c21e1857b12486ed2e89cd89d",
    "author": "cnbc.com",
    "url": "https://www.cnbc.com/2018/02/20/the-associated-press-ultragenyx-reports-4q-loss.html",
    "ord_in_thread": 0,
    "title": "Ultragenyx reports 4Q loss",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "NOVATO, Calif. (AP) _ Ultragenyx Pharmaceutical Inc. (RARE) on Tuesday reported a loss of $81.7 million in its fourth quarter.\nOn a per-share basis, the Novato, California-based company said it had a loss of $1.89. Losses, adjusted for pretax gains, came to $2.27 per share.\nThe results fell short of Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of $2 per share.\nThe biotechnology company posted revenue of $2.4 million in the period.\nFor the year, the company reported that its loss widened to $302.1 million, or $7.12 per share. Revenue was reported as $2.6 million.\nUltragenyx shares have risen roughly 4 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $48.18, a fall of 37 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on RARE at https://www.zacks.com/ap/RARE",
    "published": "2018-02-21T00:17:00.000+02:00",
    "crawled": "2018-02-21T01:28:06.017+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "novato",
        "ap",
        "ultragenyx",
        "pharmaceutical",
        "rare",
        "tuesday",
        "reported",
        "loss",
        "million",
        "fourth",
        "quarter",
        "basis",
        "novato",
        "company",
        "said",
        "loss",
        "loss",
        "adjusted",
        "pretax",
        "gain",
        "came",
        "per",
        "share",
        "result",
        "fell",
        "short",
        "wall",
        "street",
        "expectation",
        "average",
        "estimate",
        "eight",
        "analyst",
        "surveyed",
        "zacks",
        "investment",
        "research",
        "loss",
        "per",
        "share",
        "biotechnology",
        "company",
        "posted",
        "revenue",
        "million",
        "period",
        "year",
        "company",
        "reported",
        "loss",
        "widened",
        "million",
        "per",
        "share",
        "revenue",
        "reported",
        "million",
        "ultragenyx",
        "share",
        "risen",
        "roughly",
        "percent",
        "since",
        "beginning",
        "year",
        "final",
        "minute",
        "trading",
        "tuesday",
        "share",
        "hit",
        "fall",
        "percent",
        "last",
        "month",
        "story",
        "generated",
        "automated",
        "insight",
        "http",
        "using",
        "data",
        "zacks",
        "investment",
        "research",
        "access",
        "zacks",
        "stock",
        "report",
        "rare",
        "http"
    ]
}